Resuming warfarin after GIB event decreases risk of thrombosis, death


Patients who experience a warfarin-associated gastrointestinal tract bleeding event should resume anticoagulation therapy during the 90 days following the event to decrease the risk of thrombosis and death, according to a study published online in the Archives of Internal Medicine.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.